Articles
View all
Conditions
  • Psoriasis Psoriasis
    Psoriasis is a chronic skin condition that causes cells to build up and form dry, itchy patches on the skin, nails, and joints. This autoimmune disorder causes the skin to grow faster than usual, and although psoriasis is a long-term disease that affects approximately 125 million individuals worldwide, there is no existing cure.
    Read more
  • Vitiligo Vitiligo
    Vitiligo is a chronic skin condition that causes loss of skin color in segmented areas of an individual’s body, including inside of the mouth, hair, face, hands, genital area, and more. Vitiligo, also called leukoderma, affects over one percent of the world’s population, and its symptoms may worsen with time. Although there is no cure for Vitiligo, treatments available may help restore color to the affected skin.
    Read more
  • Acne Acne
    Acne, a widespread skin condition, is caused by a combination of factors, including excess sebum (oil) production, clogged hair follicles, bacteria (particularly Propionibacterium acnes), and inflammation.
    Read more
  • Dermatitis Dermatitis
    Dermatitis is a chronic skin condition often caused by allergies, irritants, and genetic factors. Although its symptoms can come out rather quickly, even mild cases of dermatitis can take a few weeks to resolve, and more severe issues usually require long-term management.
    Read more
  • Eczema Eczema
    Eczema, or atopic dermatitis, is a long-lasting skin condition that leads to dry, red, itchy, and bumpy skin. In severe cases, Eczema can lead to painful blisters and ooze liquid. Unfortunately, there is not any clear evidence identifying what causes Eczema.
    Read more
View all
Clinical Studies
  • Vitiligo Phototherapy At Home: Hand-Held NB-UVB

    Eleftheriadou and colleagues (2014) noted that hand-held NB-UVB units are light-weight devices that may overcome the need to treat vitiligo in hospital-based phototherapy cabinets, allowing early treatment at home that may enhance the likelihood of successful re-pigmentation.

    Published on March 25, 2024

    Read more
  • Comparison of NB-UVB Combination Therapy Regimens for the Treatment of Vitiligo

    Zhu et al (2023) noted that vitiligo is an autoimmune disease and some guidelines for the management of vitiligo encouraged the use of NB-UVB combination therapies to enhance re-pigmentation.  In a systematic review and network meta-analysis, these researchers compared the effectiveness of current NB-UVB combination regimen at the improvement in re-pigmentation.  They searched the electronic […]

    Published on February 23, 2024

    Read more
  • Oral Therapy & Narrow-Band UVB

    Lee and associates (2016) noted that systemic corticosteroids have been used to arrest the progression of vitiligo; however, side effects have been a constant issue.  In a retrospective study, these researchers examined the efficacy and side effect of oral mini-pulse (OMP) therapy with methylprednisolone (MPD) combined with narrow-band ultraviolet B (NB-UVB) for adults with non-segmental […]

    Published on February 23, 2024

    Read more
  • Apremilast & Narrowband UVB for the Vitiligo Treatment

    Khemis and colleagues (2020) noted that scientific rationale and encouraging first clinical results suggested the interest of using apremilast for treating vitiligo.  In a 52-week, prospective, randomized, placebo-controlled study, these researchers compared the efficacy of apremilast in combination therapy with narrow-band ultraviolet B (NB-UVB) versus placebo and NB-UVB treatment for re-pigmentation in patients with non-segmental […]

    Published on February 23, 2024

    Read more
View all